Piozena Plus Tablet 15 mg+500 mg combines Pioglitazone 15 mg and Metformin Hydrochloride 500 mg, two effective oral antidiabetic agents, in a single tablet. This combination is designed for the management of type 2 diabetes mellitus in patients whose blood sugar is not adequately controlled with diet, exercise, or monotherapy with either agent. By targeting different mechanisms involved in glucose regulation, Piozena Plus provides enhanced glycemic control.

Pioglitazone improves insulin sensitivity in peripheral tissues such as muscle and fat, allowing the body to utilize glucose more effectively. Metformin reduces hepatic glucose production and improves insulin action in peripheral tissues, lowering fasting and postprandial blood glucose. Together, they address both insulin resistance and excessive hepatic glucose output, which are core pathophysiological features of type 2 diabetes.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Piozena Plus Tablet 15 mg+500 mg is indicated for:

• Management of type 2 diabetes mellitus in adults inadequately controlled with diet and exercise alone

• Combination therapy for patients not achieving target blood sugar with single-agent therapy

• Use alongside lifestyle modifications such as diet control, regular exercise, and weight management

• Suitable for patients who require dual-action therapy targeting insulin resistance and hepatic glucose production

This combination therapy simplifies treatment by reducing pill burden and improving patient adherence.

Dosage and Administration

• The usual starting dose is 1 tablet twice daily, preferably with meals to minimize gastrointestinal discomfort caused by Metformin.

• Dose adjustments are guided by blood glucose levels and patient tolerance, under medical supervision.

• Regular monitoring of fasting and postprandial blood glucose is recommended to evaluate efficacy.

• Kidney function should be assessed before starting therapy, as Metformin is contraindicated in patients with significant renal impairment.

• Tablets should be swallowed whole with water; do not crush or chew.

Benefits of Piozena Plus Tablet 15 mg+500 mg

• Provides dual-action blood glucose control through insulin sensitization and reduced hepatic glucose production

• Effective in lowering fasting and postprandial blood sugar levels

• Convenient combination tablet reduces the number of pills taken daily

• Supports improved glycemic control in patients inadequately managed with monotherapy

• May help improve lipid profiles and reduce the risk of diabetes-related complications when used with lifestyle measures

Possible Side Effects

Common side effects may include:

• Gastrointestinal disturbances such as nausea, diarrhea, or abdominal discomfort (mainly due to Metformin)

• Mild edema or weight gain (mainly due to Pioglitazone)

• Headache or dizziness

• Rare liver enzyme elevations or hepatotoxicity

Serious side effects are uncommon but may include:

• Exacerbation of heart failure in patients with pre-existing cardiac conditions

• Lactic acidosis, a rare but serious condition associated with Metformin

• Increased risk of bladder cancer with long-term Pioglitazone use

Patients should report persistent or severe symptoms to their healthcare provider immediately.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

• Not recommended in type 1 diabetes or diabetic ketoacidosis

• Avoid in patients with renal or hepatic impairment

• Use cautiously in patients with heart failure or cardiovascular disease

• Regular monitoring of blood sugar, liver function, kidney function, and cardiovascular health is advised

• Pregnant or breastfeeding women should use this medication only under medical supervision

Storage

Store below 30°C in a dry, light-protected place. Keep out of reach of children. Do not use after the expiration date.

Piozena Plus Tablet 15 mg+500 mg offers an effective, convenient dual therapy option for type 2 diabetes, improving glycemic control by addressing multiple underlying mechanisms while promoting adherence through combination dosing.